Breast Cancer
Conditions
Interventions
Group of breast cancer:None
Group of benign breast tumors:None
Sponsors
Shaoxing Second Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All breast cancer patients (Stage I to Stage III) who meet the inclusion criteria, as well as patients with benign breast lesions undergoing surgical treatment, will be included. Breast cancer patients will undergo diagnostic staging within four weeks before the start of treatment; metastatic lesions will be excluded during the initial diagnostic staging. Specific inclusion criteria should refer to the "relevant clinical guidelines".
Exclusion criteria
Exclusion criteria: 1.Previously received any form of immunotherapy; 2.Diagnosed with or treated for malignancies other than breast cancer; 3.Presence of any active autoimmune disease or history of such; 4.Patients with uncontrolled diabetes; 5.Pregnant or lactating women; 6.Duplicate peripheral blood samples collected from the same subject at different time points; 7.Peripheral blood samples with unclear sample type, sample collection time, or case information; 8.Peripheral blood samples contaminated due to experimental operations or samples with insufficient quantity for testing; 9.Peripheral blood samples that do not meet storage conditions; 10.Subject samples collected at time points not in accordance with the protocol requirements; 11.Subjects with neurodegenerative or psychiatric disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MitoDye,Mitochondria-specific markers; | — |
Countries
China
Contacts
Public ContactGuodong Ruan
Shaoxing Second Hospital
Outcome results
None listed